Breaking News

UNIGEN Implements Werum’s PAS-X MES

Gifu site is among largest plants for production of flu vaccines and biopharmaceutical products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

UNIGEN, a Japanese biopharma company, has implemented Werum’s PAS-X Manufacturing Execution System (MES) into operationwithin four months. UNIGEN implemented PAS-X using Werum’s four-phased fast-track implementation methodology: Ready, Fit, Build and Run, which incorporates flexible PAS-X content and library based MBR modeling.   UNIGEN’s Gifu site is one of the largest plants for production of recombinant influenza vaccines and contract manufacturing of biopharmaceutical products. T...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters